Abstract
Introduction
The objective of this systematic review is to describe polysubstance studies and their prevalence estimates among pregnant people in the US.
Methods
This review was not subject to protocol preparation or registration with the International Prospective Register of Systematic Reviews (PROSPERO) because outcome data were not reported. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist was followed. Four scientific literature databases were used to identify articles published from January 1, 2009 to June 3, 2020 reporting prenatal exposure to two or more substances in the US. A standardized process of title and abstract screening followed by a two-phase full-text review was used to assess study eligibility.
Results
A total of 119 studies were included: 7 case–control studies, 7 clinical trials, 76 cohort studies, and 29 cross-sectional studies. Studies varied with respect to study design, time period, region, sampling and participant selection, substances assessed, and method of exposure ascertainment. Commonly reported polysubstance prevalence estimates among studies of pregnant people included combinations with alcohol, marijuana, and/or tobacco/nicotine. The range of prevalence estimates was wide (alcohol 1–99%; marijuana 3–95%; tobacco/nicotine 2–95%).
Discussion
Polysubstance use during pregnancy is common, especially with alcohol, marijuana, and/or tobacco/nicotine. Future research to assess polysubstance use during pregnancy could help better describe patterns and ultimately help mitigate its effects on maternal and infant health outcomes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Alhusen, J. L., Lucea, M. B., Bullock, L., & Sharps, P. (2013). Intimate partner violence, substance use, and adverse neonatal outcomes among urban women. Journal of Pediatrics, 163(2), 471–476. https://doi.org/10.1016/j.jpeds.2013.01.036
Aliyu, M. H., Wilson, R. E., Zoorob, R., Brown, K., Alio, A. P., Clayton, H., & Salihu, H. M. (2009). Prenatal alcohol consumption and fetal growth restriction: Potentiation effect by concomitant smoking. Nicotine & Tobacco Research, 11(1), 36–43. https://doi.org/10.1093/ntr/ntn014
Allen, J. W., Bennett, D. S., Carmody, D. P., Wang, Y., & Lewis, M. (2014). Adolescent risk-taking as a function of prenatal cocaine exposure and biological sex. Neurotoxicology and Teratology, 41, 65–70. https://doi.org/10.1016/j.ntt.2013.12.003
Almario, C. V., Seligman, N. S., Dysart, K. C., Berghella, V., & Baxter, J. K. (2009). Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. American Journal of Obstetrics and Gynecology, 201(3), 326.e321-326.e326. https://doi.org/10.1016/j.ajog.2009.05.052
Ashford, K., Fallin-Bennett, A., McCubbin, A., Wiggins, A., Barnhart, S., & Lile, J. (2019). Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being. Neurotoxicology and Teratology, 73, 42–48. https://doi.org/10.1016/j.ntt.2019.03.002
Bada, H. S., Bann, C. M., Whitaker, T. M., Bauer, C. R., Shankaran, S., Lagasse, L., Lester, B. M., Hammond, J., & Higgins, R. (2012). Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures. Pediatrics, 130(6), e1479-1488. https://doi.org/10.1542/peds.2011-3306
Baer, R. J., Chambers, C. D., Ryckman, K. K., Oltman, S. P., Norton, M. E., & Jelliffe-Pawlowski, L. L. (2017). Risk of preterm birth among women using drugs during pregnancy with elevated alpha-fetoprotein. Journal of Perinatology, 37(3), 220–225. https://doi.org/10.1038/jp.2016.224
Baewert, A., Jagsch, R., Winklbaur, B., Kaiser, G., Thau, K., Unger, A., Aschauer, C., Weninger, M., & Metz, V. (2012). Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. European Addiction Research, 18(3), 130–139. https://doi.org/10.1159/000335082
Bailey, B. A., McCook, J. G., Hodge, A., & McGrady, L. (2012). Infant birth outcomes among substance using women: Why quitting smoking during pregnancy is just as important as quitting illicit drug use. Maternal and Child Health Journal, 16(2), 414–422. https://doi.org/10.1007/s10995-011-0776-y
Bakhireva, L. N., Holbrook, B. D., Shrestha, S., Leyva, Y., Ashley, M., Cano, S., Lowe, J., Stephen, J. M., & Leeman, L. (2019). Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5–8 months of age. Early Human Development, 128, 69–76. https://doi.org/10.1016/j.earlhumdev.2018.10.010
Barlow, A., Mullany, B. C., Neault, N., Davis, Y., Billy, T., Hastings, R., Coho-Mescal, V., Lake, K., Powers, J., Clouse, E., Reid, R., & Walkup, J. T. (2010). Examining correlates of methamphetamine and other drug use in pregnant American Indian adolescents. American Indian and Alaska Native Mental Health Research, 17(1), 1–24. https://doi.org/10.5820/aian.1701.2010.1
Bashir, R., Surian, D., & Dunn, A. G. (2018). Time-to-update of systematic reviews relative to the availability of new evidence. Systematic Reviews, 7(1), 195. https://doi.org/10.1186/s13643-018-0856-9
Beatty, J. R., Svikis, D. S., & Ondersma, S. J. (2012). Prevalence and perceived financial costs of marijuana versus tobacco use among urban low-income pregnant women. Journal of Addiction Research & Therapy. https://doi.org/10.4172/2155-6105.1000135
Belur, J., Tompson, L., Thornton, A., & Simon, M. (2021). Interrater reliability in systematic review methodology: Exploring variation in coder decision-making. Sociological Methods & Research, 50(2), 837–865. https://doi.org/10.1177/0049124118799372
Bolin, E. H., Escalona-Vargas, D., Daily, J. A., Siegel, E. R., Lowery, C. L., Coker, J., Stowe, Z. N., & Eswaran, H. (2019). Magnetocardiographic identification of prolonged fetal corrected QT interval in women receiving treatment for opioid use disorder. The Journal of Obstetrics and Gynaecology Research, 45(10), 1989–1996. https://doi.org/10.1111/jog.14055
Brogly, S. B., Saia, K. E., Werler, M. M., Regan, E., & Hernandez-Diaz, S. (2018). Prenatal treatment and outcomes of women with opioid use disorder. Obstetrics and Gynecology, 132(4), 916–922. https://doi.org/10.1097/AOG.0000000000002881
Bruzelius, E., & Martins, S. S. (2022). US trends in drug overdose mortality among pregnant and postpartum persons, 2017–2020. JAMA, 328(21), 2159–2161. https://doi.org/10.1001/jama.2022.17045
Campbell, J., Matoff-Stepp, S., Velez, M. L., Cox, H. H., & Laughon, K. (2021). Pregnancy-associated deaths from homicide, suicide, and drug overdose: Review of research and the intersection with intimate partner violence. Journal of Women’s Health (2002), 30(2), 236–244. https://doi.org/10.1089/jwh.2020.8875
Centers for Disease Control and Prevention. (2014). Alcohol screening and counseling: an effective but underused health service. CDC Vital Signs [Fact sheet]. U.S. Department of Health and Human Services. https://www.cdc.gov/vitalsigns/pdf/2014-01-vitalsigns.pdf
Centers for Disease Control and Prevention. (2021). Other Drugs. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Retrieved April 15, 2022 from https://www.cdc.gov/drugoverdose/deaths/other-drugs.html
Chabarria, K. C., Racusin, D. A., Antony, K. M., Kahr, M., Suter, M. A., Mastrobattista, J. M., & Aagaard, K. M. (2016). Marijuana use and its effects in pregnancy. American Journal of Obstetrics and Gynecology, 215(4), 506501–506507. https://doi.org/10.1016/j.ajog.2016.05.044
Chambers, C. D., Coles, C., Kable, J., Akshoomoff, N., Xu, R., Zellner, J. A., Honerkamp-Smith, G., Manning, M. A., Adam, M. P., & Jones, K. L. (2019). Fetal alcohol spectrum disorders in a pacific Southwest City: Maternal and child characteristics. Alcoholism, Clinical and Experimental Research, 43(12), 2578–2590. https://doi.org/10.1111/acer.14213
Chisolm, M. S., Tuten, M., Brigham, E. C., Strain, E. C., & Jones, H. E. (2009). Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients. The American Journal on Addictions, 18(5), 422–429. https://doi.org/10.3109/10550490903077721
Choo, R. E., Huestis, M. A., Schroeder, J. R., Shin, A. S., & Jones, H. E. (2004). Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug and Alcohol Dependence, 75(3), 253–260. https://doi.org/10.1016/j.drugalcdep.2004.03.012
Chung, E. K., Nurmohamed, L., Mathew, L., Elo, I. T., Coyne, J. C., & Culhane, J. F. (2010). Risky health behaviors among mothers-to-be: The impact of adverse childhood experiences. Academic Pediatric, 10(4), 245–251. https://doi.org/10.1016/j.acap.2010.04.003
Ciccarone, D. (2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 34(4), 344–350. https://doi.org/10.1097/YCO.0000000000000717
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020). Polysubstance use: A broader understanding of substance use during the opioid crisis. American Journal of Public Health, 110(2), 244–250. https://doi.org/10.2105/AJPH.2019.305412
Coleman-Cowger, V. H., Oga, E. A., Peters, E. N., & Mark, K. (2018a). Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicology and Teratology, 68, 84–90. https://doi.org/10.1016/j.ntt.2018.06.001
Coleman-Cowger, V. H., Pickworth, W. B., Lordo, R. A., & Peters, E. N. (2018b). Cigar and marijuana blunt use among pregnant and nonpregnant women of reproductive age in the United States, 2006–2016. American Journal of Public Health, 108(8), 1073–1075. https://doi.org/10.2105/AJPH.2018.304469
Conner, S. N., Carter, E. B., Tuuli, M. G., Macones, G. A., & Cahill, A. G. (2015). Maternal marijuana use and neonatal morbidity. American Journal of Obstetrics and Gynecology, 213(3), 422421–422424. https://doi.org/10.1016/j.ajog.2015.05.050
Covidence systematic review software. (2020). Veritas Health Innovation. https://support.covidence.org/help/how-can-i-cite-covidence
Crume, T. L., Juhl, A. L., Brooks-Russell, A., Hall, K. E., Wymore, E., & Borgelt, L. M. (2018). Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: The association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. Journal of Pediatrics, 197, 90–96. https://doi.org/10.1016/j.jpeds.2018.02.005
De Genna, N., Goldschmidt, L., & Richardson, G. A. (2014). Prenatal cocaine exposure and age of sexual initiation: Direct and indirect effects. Drug and Alcohol Dependence, 145, 194–200. https://doi.org/10.1016/j.drugalcdep.2014.10.011
de Wit, M., Goldberg, A., & Chelmow, D. (2013). Alcohol use disorders and hospital-acquired infections in women undergoing cesarean delivery. Obstetrics and Gynecology, 122(1), 72–78. https://doi.org/10.1097/AOG.0b013e318297be8d
Desai, R. J., Huybrechts, K. F., Hernandez-Diaz, S., Mogun, H., Patorno, E., Kaltenbach, K., Kerzner, L. S., & Bateman, B. T. (2015). Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: Population based cohort study. BMJ, 350, h2102. https://doi.org/10.1136/bmj.h2102
Dukes, K., Tripp, T., Willinger, M., Odendaal, H., Elliott, A. J., Kinney, H. C., Robinson, F., Petersen, J. M., Raffo, C., Hereld, D., Groenewald, C., Angal, J., Hankins, G., Burd, L., Fifer, W. P., Myers, M. M., Hoffman, H. J., Sullivan, L., & Network, P. (2017). Drinking and smoking patterns during pregnancy: Development of group-based trajectories in the Safe Passage Study. Alcohol, 62, 49–60. https://doi.org/10.1016/j.alcohol.2017.03.001
Eggleston, A. M., Calhoun, P. S., Svikis, D. S., Tuten, M., Chisolm, M. S., & Jones, H. E. (2009). Suicidality, aggression, and other treatment considerations among pregnant, substance-dependent women with posttraumatic stress disorder. Comprehensive Psychiatry, 50(5), 415–423. https://doi.org/10.1016/j.comppsych.2008.11.004
Eiden, R. D., Shisler, S., Granger, D. A., Schuetze, P., Colangelo, J., & Huestis, M. A. (2020). Prenatal tobacco and cannabis exposure: Associations with cortisol reactivity in early school age children. International Journal of Behavioral Medicine, 27(3), 343–356. https://doi.org/10.1007/s12529-020-09875-8
Encyclopaedia Britannica, Inc. (2020). Legal Recreational Marijuana States and DC. https://marijuana.procon.org/legal-recreational-marijuana-states-and-dc/
England, L. J., Bennett, C., Denny, C. H., Honein, M. A., Gilboa, S. M., Kim, S. Y., Guy, G. P., Jr., Tran, E. L., Rose, C. E., Bohm, M. K., & Boyle, C. A. (2020). Alcohol use and co-use of other substances among pregnant females aged 12–44 years—United States, 2015–2018. MMWR. Morbidity and Mortality Weekly Report, 69(31), 1009–1014. https://doi.org/10.15585/mmwr.mm6931a1
Forray, A., Gotman, N., Kershaw, T., & Yonkers, K. A. (2014). Perinatal smoking and depression in women with concurrent substance use. Addictive Behaviors, 39(4), 749–756. https://doi.org/10.1016/j.addbeh.2013.12.008
Gaalema, D. E., Higgins, S. T., Pepin, C. S., Heil, S. H., & Bernstein, I. M. (2013). Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation. Nicotine & Tobacco Research, 15(5), 987–991. https://doi.org/10.1093/ntr/nts220
Gallagher, L. G., Webster, T. F., & Aschengrau, A. (2017). Exploring associations between prenatal solvent exposures and teenage drug and alcohol use: A retrospective cohort study. Environmental Health, 16(1), 26. https://doi.org/10.1186/s12940-017-0232-6
Garrison-Desany, H. M., Nawa, N., Kim, Y., Ji, Y., Susan Chang, H. Y., Hong, X., Wang, G., Pearson, C., Zuckerman, B. S., Wang, X., & Surkan, P. J. (2020). Polydrug use during pregnancy and preterm birth in a low-income, Multiethnic Birth Cohort, Boston, 1998–2018. Public Health Reports, 135(3), 383–392. https://doi.org/10.1177/0033354920915437
Gauthier, T. W., Kable, J. A., Burwell, L., Coles, C. D., & Brown, L. A. (2010). Maternal alcohol use during pregnancy causes systemic oxidation of the glutathione redox system. Alcoholism, Clinical and Experimental Research, 34(1), 123–130. https://doi.org/10.1111/j.1530-0277.2009.01072.x
Godleski, S. A., Shisler, S., Eiden, R. D., & Huestis, M. A. (2018). Co-use of tobacco and marijuana during pregnancy: Pathways to externalizing behavior problems in early childhood. Neurotoxicology and Teratology, 69, 39–48. https://doi.org/10.1016/j.ntt.2018.07.003
Goldschmidt, L., Cornelius, M. D., & Day, N. L. (2012). Prenatal cigarette smoke exposure and early initiation of multiple substance use. Nicotine & Tobacco Research, 14(6), 694–702. https://doi.org/10.1093/ntr/ntr280
Good, M. M., Solt, I., Acuna, J. G., Rotmensch, S., & Kim, M. J. (2010). Methamphetamine use during pregnancy: Maternal and neonatal implications. Obstetrics and Gynecology, 116(2 Pt 1), 330–334. https://doi.org/10.1097/AOG.0b013e3181e67094
Grant, T. M., Huggins, J. E., Sampson, P. D., Ernst, C. C., Barr, H. M., & Streissguth, A. P. (2009). Alcohol use before and during pregnancy in western Washington, 1989–2004: Implications for the prevention of fetal alcohol spectrum disorders. American Journal of Obstetrics and Gynecology, 200(3), 278 e271-278. https://doi.org/10.1016/j.ajog.2008.09.871
Gray, T. R., Choo, R. E., Concheiro, M., Williams, E., Elko, A., Jansson, L. M., Jones, H. E., & Huestis, M. A. (2010a). Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction, 105(12), 2151–2159. https://doi.org/10.1111/j.1360-0443.2010.03097.x
Gray, T. R., Eiden, R. D., Leonard, K. E., Connors, G. J., Shisler, S., & Huestis, M. A. (2010b). Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clinical Chemistry, 56(9), 1442–1450. https://doi.org/10.1373/clinchem.2010.147876
Guille, C., Simpson, A. N., Douglas, E., Boyars, L., Cristaldi, K., McElligott, J., Johnson, D., & Brady, K. (2020). Treatment of opioid use disorder in pregnant women via telemedicine: A nonrandomized controlled trial. JAMA Network Open, 3(1), e1920177. https://doi.org/10.1001/jamanetworkopen.2019.20177
Hand, D. J., Short, V. L., & Abatemarco, D. J. (2017). Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region. Journal of Substance Abuse Treatment, 76, 58–63. https://doi.org/10.1016/j.jsat.2017.01.011
Harrison, P. A., & Sidebottom, A. C. (2009). Alcohol and drug use before and during pregnancy: An examination of use patterns and predictors of cessation. Maternal and Child Health Journal, 13(3), 386–394. https://doi.org/10.1007/s10995-008-0355-z
Hensley, L., Sulo, S., Kozmic, S., & Parilla, B. V. (2018). Opioid addiction in pregnancy: Does depression negatively impact adherence with prenatal care? Journal of Addiction Medicine, 12(1), 61–64. https://doi.org/10.1097/ADM.0000000000000364
Holtrop, J. S., Meghea, C., Raffo, J. E., Biery, L., Chartkoff, S. B., & Roman, L. (2010). Smoking among pregnant women with Medicaid insurance: Are mental health factors related? Maternal and Child Health Journal, 14(6), 971–977. https://doi.org/10.1007/s10995-009-0530-x
Huybrechts, K. F., Bateman, B. T., Desai, R. J., Hernandez-Diaz, S., Rough, K., Mogun, H., Kerzner, L. S., Davis, J. M., Stover, M., Bartels, D., Cottral, J., & Patorno, E. (2017). Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ, 358, j3326. https://doi.org/10.1136/bmj.j3326
Jansson, L. M., Velez, M., McConnell, K., Spencer, N., Tuten, M., Jones, H. E., King, V. L., Gandotra, N., Milio, L. A., Voegtline, K., & DiPietro, J. A. (2017). Maternal buprenorphine treatment and fetal neurobehavioral development. American Journal of Obstetrics and Gynecology, 216(5), 529 e521-529 e528. https://doi.org/10.1016/j.ajog.2017.01.040
Jarlenski, M., Barry, C. L., Gollust, S., Graves, A. J., Kennedy-Hendricks, A., & Kozhimannil, K. (2017). Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons. American Journal of Public Health, 107(8), 1308–1310. https://doi.org/10.2105/AJPH.2017.303825
Jarlenski, M., & Krans, E. E. (2021). Co-occurring substance use disorders identified among delivery hospitalizations in the United States. Journal of Addiction Medicine, 15(6), 504–507. https://doi.org/10.1097/ADM.0000000000000792
Jarlenski, M. P., Paul, N. C., & Krans, E. E. (2020). Polysubstance use among pregnant women with opioid use disorder in the United States, 2007–2016. Obstetrics & Gynecology, 136(3), 556–564. https://doi.org/10.1097/AOG.0000000000003907
Jones, H. E., Heil, S. H., Tuten, M., Chisolm, M. S., Foster, J. M., O’Grady, K. E., & Kaltenbach, K. (2013). Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes. Drug and Alcohol Dependence, 131(3), 271–277. https://doi.org/10.1016/j.drugalcdep.2012.11.019
Kiblawi, Z. N., Smith, L. M., Diaz, S. D., LaGasse, L. L., Derauf, C., Newman, E., Shah, R., Arria, A., Huestis, M., Haning, W., Strauss, A., DellaGrotta, S., Dansereau, L. M., Neal, C., & Lester, B. (2014). Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: Results from the IDEAL study. Substance Abuse, 35(1), 68–73. https://doi.org/10.1080/08897077.2013.814614
Kim, S. Y., England, L., Dietz, P. M., Morrow, B., & Perham-Hester, K. A. (2009). Prenatal cigarette smoking and smokeless tobacco use among Alaska native and white women in Alaska, 1996–2003 [Comparative Study Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Maternal & Child Health Journal, 13(5), 652–659. https://doi.org/10.1007/s10995-008-0402-9
Ko, J. Y., Farr, S. L., Tong, V. T., Creanga, A. A., & Callaghan, W. M. (2015). Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. American Journal of Obstetrics and Gynecology, 213(2), 201 e201-201 e210. https://doi.org/10.1016/j.ajog.2015.03.021
Ko, J. Y., Tong, V. T., Bombard, J. M., Hayes, D. K., Davy, J., & Perham-Hester, K. A. (2018). Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study. Drug and Alcohol Dependence, 187, 72–78. https://doi.org/10.1016/j.drugalcdep.2018.02.017
Kozhimannil, K. B., Chantarat, T., Ecklund, A. M., Henning-Smith, C., & Jones, C. (2019). Maternal opioid use disorder and neonatal abstinence syndrome among rural US residents, 2007–2014. The Journal of Rural Health, 35(1), 122–132. https://doi.org/10.1111/jrh.12329
Kozhimannil, K. B., Graves, A. J., Levy, R., & Patrick, S. W. (2017). Nonmedical use of prescription opioids among pregnant U.S. women. Women’s Health Issues, 27(3), 308–315. https://doi.org/10.1016/j.whi.2017.03.001
Kreitinger, C., Gutierrez, H., Hamidovic, A., Schmitt, C., Sarangarm, P., Rayburn, W. F., Leeman, L., & Bakhireva, L. N. (2016). The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment. The Journal of Maternal-Fetal & Neonatal Medicine, 29(5), 783–788. https://doi.org/10.3109/14767058.2015.1018168
Kreshak, A., Villano, J., Clark, A., Deak, P., Clark, R., & Miller, C. (2016). A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry. American Journal of Drug and Alcohol Abuse, 42(2), 178–186. https://doi.org/10.3109/00952990.2015.1116540
LaGasse, L. L., Wouldes, T., Newman, E., Smith, L. M., Shah, R. Z., Derauf, C., Huestis, M. A., Arria, A. M., Della Grotta, S., Wilcox, T., & Lester, B. M. (2011). Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicology and Teratology, 33(1), 166–175. https://doi.org/10.1016/j.ntt.2010.06.009
Lappen, J. R., Stark, S., Bailit, J. L., & Gibson, K. S. (2020). Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome. American Journal of Obstetrics and Gynecology MFM, 2(1), 100075. https://doi.org/10.1016/j.ajogmf.2019.100075
Lee, E., Pluym, I. D., Wong, D., Kwan, L., Varma, V., & Rao, R. (2020). The impact of state legalization on rates of marijuana use in pregnancy in a universal drug screening population. Journal of Maternal-Fetal and Neonatal Medicine. https://doi.org/10.1080/14767058.2020.1765157
Leszko, M., Keenan-Devlin, L., Adam, E. K., Buss, C., Grobman, W., Simhan, H., Wadhwa, P., Mroczek, D. K., & Borders, A. (2020). Are personality traits associated with smoking and alcohol use prior to and during pregnancy? PLoS ONE, 15(5), e0232668. https://doi.org/10.1371/journal.pone.0232668
Lopez, W. D., Konrath, S. H., & Seng, J. S. (2011). Abuse-related post-traumatic stress, coping, and tobacco use in pregnancy. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 40(4), 422–431. https://doi.org/10.1111/j.1552-6909.2011.01261.x
Lu, L. H., Johnson, A., O’Hare, E. D., Bookheimer, S. Y., Smith, L. M., O’Connor, M. J., & Sowell, E. R. (2009). Effects of prenatal methamphetamine exposure on verbal memory revealed with functional magnetic resonance imaging. Journal of Developmental and Behavioral Pediatrics, 30(3), 185–192. https://doi.org/10.1097/DBP.0b013e3181a7ee6b
MacAfee, L. K., Dalton, V., & Terplan, M. (2019). Pregnancy intention, risk perception, and contraceptive use in pregnant women who use drugs. Journal of Addiction Medicine, 13(3), 177–181. https://doi.org/10.1097/ADM.0000000000000471
Maeda, A., Bateman, B. T., Clancy, C. R., Creanga, A. A., & Leffert, L. R. (2014). Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes. Anesthesiology, 121(6), 1158–1165. https://doi.org/10.1097/ALN.0000000000000472
Mark, K., Desai, A., & Terplan, M. (2016). Marijuana use and pregnancy: Prevalence, associated characteristics, and birth outcomes. Archives of Women’s Mental Health, 19(1), 105–111. https://doi.org/10.1007/s00737-015-0529-9
Mark, K., Gryczynski, J., Axenfeld, E., Schwartz, R. P., & Terplan, M. (2017). Pregnant women’s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm. Journal of Addiction Medicine, 11(3), 211–216. https://doi.org/10.1097/ADM.0000000000000299
Massey, S. H., Mroczek, D. K., Reiss, D., Miller, E. S., Jakubowski, J. A., Graham, E. K., Shisler, S. M., McCallum, M., Huestis, M. A., Ganiban, J. M., Shaw, D. S., Leve, L. D., Eiden, R. D., Stroud, L. R., & Neiderhiser, J. M. (2018). Additive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003–2015). Neurotoxicology and Teratology, 68, 97–106. https://doi.org/10.1016/j.ntt.2018.06.002
May, P. A., Hasken, J. M., Baete, A., Russo, J., Elliott, A. J., Kalberg, W. O., Buckley, D., Brooks, M., Ortega, M. A., Hedrick, D. M., Tabachnick, B. G., Abdul-Rahman, O., Adam, M. P., Jewett, T., Robinson, L. K., Manning, M. A., & Hoyme, H. E. (2020a). Fetal alcohol spectrum disorders in a Midwestern City: Child characteristics, maternal risk traits, and prevalence. Alcoholism, Clinical and Experimental Research, 44(4), 919–938. https://doi.org/10.1111/acer.14314
May, P. A., Hasken, J. M., Bozeman, R., Jones, J. V., Burns, M. K., Goodover, J., Kalberg, W. O., Buckley, D., Brooks, M., Ortega, M. A., Elliott, A. J., Hedrick, D. M., Tabachnick, B. G., Abdul-Rahman, O., Adam, M. P., Jewett, T., Robinson, L. K., Manning, M. A., & Hoyme, H. E. (2020b). Fetal alcohol spectrum disorders in a rocky mountain Region City: Child characteristics, maternal risk traits, and prevalence. Alcoholism, Clinical and Experimental Research, 44(4), 900–918. https://doi.org/10.1111/acer.14315
May, P. A., Hasken, J. M., Stegall, J. M., Mastro, H. A., Kalberg, W. O., Buckley, D., Brooks, M., Hedrick, D. M., Ortega, M. A., Elliott, A. J., Tabachnick, B. G., Abdul-Rahman, O., Adam, M. P., Robinson, L. K., Manning, M. A., Jewett, T., & Hoyme, H. E. (2020c). Fetal alcohol spectrum disorders in a Southeastern county of the United States: Child characteristics and maternal risk traits. Alcoholism, Clinical and Experimental Research, 44(4), 939–959. https://doi.org/10.1111/acer.14313
May, P. A., Keaster, C., Bozeman, R., Goodover, J., Blankenship, J., Kalberg, W. O., Buckley, D., Brooks, M., Hasken, J., Gossage, J. P., Robinson, L. K., Manning, M., & Hoyme, H. E. (2015). Prevalence and characteristics of fetal alcohol syndrome and partial fetal alcohol syndrome in a Rocky Mountain Region City. Drug and Alcohol Dependence, 155, 118–127. https://doi.org/10.1016/j.drugalcdep.2015.08.006
Mbah, A. K., Alio, A. P., Fombo, D. W., Bruder, K., Dagne, G., & Salihu, H. M. (2012). Association between cocaine abuse in pregnancy and placenta-associated syndromes using propensity score matching approach. Early Human Development, 88(6), 333–337. https://doi.org/10.1016/j.earlhumdev.2011.09.005
Metz, T. D., Allshouse, A. A., Hogue, C. J., Goldenberg, R. L., Dudley, D. J., Varner, M. W., Conway, D. L., Saade, G. R., & Silver, R. M. (2017). Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. American Journal of Obstetrics and Gynecology, 217(4), 478471–478478. https://doi.org/10.1016/j.ajog.2017.05.050
Metz, V. E., Brown, Q. L., Martins, S. S., & Palamar, J. J. (2018). Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. Drug and Alcohol Dependence, 183, 261–266. https://doi.org/10.1016/j.drugalcdep.2017.11.010
Minnes, S., Min, M. O., Singer, L. T., Edguer, M., Wu, M., & Thi, P. (2012). Cocaine use during pregnancy and health outcome after 10 years. Drug and Alcohol Dependence, 126(1–2), 71–79. https://doi.org/10.1016/j.drugalcdep.2012.04.015
Morris, E., Bardsley, T., Schulte, K., Seidel, J., Shakib, J. H., Buchi, K. F., & Fung, C. M. (2020). Hospital outcomes of infants with neonatal opioid withdrawal syndrome at a tertiary care hospital with high rates of concurrent nonopioid (Polysubstance) exposure. American Journal of Perinatology. https://doi.org/10.1055/s-0040-1716490
Munn, Z., Moola, S., Lisy, K., Riitano, D., & Tufanaru, C. (2015). Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare, 13(3), 147–153. https://doi.org/10.1097/XEB.0000000000000054
Musial, J., Czarny, J., & Gadzala-Kopciuch, R. (2022). Overview of analytical methods for determining novel psychoactive substances, drugs and their metabolites in biological samples. Critical Reviews in Toxicology, 52(3), 239–258. https://doi.org/10.1080/10408444.2022.2091424
Nellhaus, E. M., Nieuwenhuizen, L., Egleton, R., Hansen, Z., Chaffin, D., Loudin, S., & Davies, T. H. (2019). History of postpartum depression as a contributor to the severity of NAS. Addictive Behaviors, 89, 78–84. https://doi.org/10.1016/j.addbeh.2018.09.011
Non-Probability Sampling. (2013). Retrieved December 21, 2022, from https://www-archive.aapor.org/Education-Resources/Reports/Non-Probability-Sampling.aspx
Obisesan, O. H., Osei, A. D., Uddin, S. M. I., Dzaye, O., Cainzos-Achirica, M., Mirbolouk, M., Orimoloye, O. A., Sharma, G., Al Rifai, M., Stokes, A., Bhatnagar, A., El Shahawy, O., Benjamin, E. J., DeFilippis, A. P., & Blaha, M. J. (2020). E-Cigarette use patterns and high-risk behaviors in pregnancy: Behavioral risk factor surveillance system, 2016–2018. American Journal of Preventive Medicine, 59(2), 187–195. https://doi.org/10.1016/j.amepre.2020.02.015
O’Connor, A. B., Kelly, B. K., & O’Brien, L. M. (2017). Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. Drug and Alcohol Dependence, 180, 200–203. https://doi.org/10.1016/j.drugalcdep.2017.08.012
O’Connor, A., O’Brien, L., & Watson, L. (2021). Implications of perinatal buprenorphine exposure on infant head circumference at birth. The Journal of Maternal-Fetal & Neonatal Medicine, 34(2), 318–322. https://doi.org/10.1080/14767058.2019.1599352
Office of the Assistant Secretary for Planning and Evaluation. (2011). HHS Implementation Guidance on Data Collection Standards for Race, Ethnicity, Sex, Primary Language, and Disability Status. Retrieved December 5, 2022 from https://aspe.hhs.gov/reports/hhs-implementation-guidance-data-collection-standards-race-ethnicity-sex-primary-language-disability-0
Oga, E. A., Mark, K., & Coleman-Cowger, V. H. (2018). Cigarette smoking status and substance use in pregnancy. Maternal and Child Health Journal, 22(10), 1477–1483. https://doi.org/10.1007/s10995-018-2543-9
Oh, S., Reingle Gonzalez, J. M., Salas-Wright, C. P., Vaughn, M. G., & DiNitto, D. M. (2017). Prevalence and correlates of alcohol and tobacco use among pregnant women in the United States: Evidence from the NSDUH 2005–2014. Preventive Medicine, 97, 93–99. https://doi.org/10.1016/j.ypmed.2017.01.006
Oncken, C., Mead, E. L., Dornelas, E. A., Kuo, C. L., Sankey, H. Z., Kranzler, H. R., & Thurlow, S. (2020). Opioid use and rate of nicotine metabolism among pregnant smokers. Nicotine & Tobacco Research, 22(6), 1046–1050. https://doi.org/10.1093/ntr/ntz073
Patrick, S. W., Barfield, W. D., Poindexter, B. B., Committee On Fetus and Newborn; Committee On Substance Use and Prevention. (2020). Neonatal Opioid Withdrawal Syndrome. Pediatrics. https://doi.org/10.1542/peds.2020-029074
Patrick, S. W., Dudley, J., Martin, P. R., Harrell, F. E., Warren, M. D., Hartmann, K. E., Ely, E. W., Grijalva, C. G., & Cooper, W. O. (2015). Prescription opioid epidemic and infant outcomes. Pediatrics, 135(5), 842–850. https://doi.org/10.1542/peds.2014-3299
Patterson, F., Seravalli, L., Hanlon, A., & Nelson, D. B. (2012). Neighborhood safety as a correlate of tobacco use in a sample of urban, pregnant women. Addictive Behaviors, 37(10), 1132–1137. https://doi.org/10.1016/j.addbeh.2012.05.011
Qato, D. M., Zhang, C., Gandhi, A. B., Simoni-Wastila, L., & Coleman-Cowger, V. H. (2020). Co-use of alcohol, tobacco, and licit and illicit controlled substances among pregnant and non-pregnant women in the United States: Findings from 2006 to 2014 National Survey on Drug Use and Health (NSDUH) data. Drug and Alcohol Dependence, 206, 107729. https://doi.org/10.1016/j.drugalcdep.2019.107729
Ram, A., Tuten, M., & Chisolm, M. S. (2016). Cigarette smoking reduction in pregnant women with opioid use disorder. Journal of Addiction Medicine, 10(1), 53–59. https://doi.org/10.1097/ADM.0000000000000186
Richardson, G. A., De Genna, N. M., Goldschmidt, L., Larkby, C., & Donovan, J. E. (2019). Prenatal cocaine exposure: Direct and indirect associations with 21-year-old offspring substance use and behavior problems. Drug and Alcohol Dependence, 195, 121–131. https://doi.org/10.1016/j.drugalcdep.2018.10.033
Roberts, S. C., & Nuru-Jeter, A. (2012). Universal screening for alcohol and drug use and racial disparities in child protective services reporting. The Journal of Behavioral Health Services & Research, 39(1), 3–16. https://doi.org/10.1007/s11414-011-9247-x
Rollins, L. G., Sokol, N. A., McCallum, M., England, L., Matteson, K., Werner, E., & Stroud, L. R. (2020). Electronic cigarette use during preconception and/or pregnancy: Prevalence, characteristics, and concurrent mental health conditions. Journal of Women’s Health (2002), 29(6), 780–788. https://doi.org/10.1089/jwh.2019.8089
Roth, D., Loudin, S., Andrews, L., Evans, J., & Davies, T. H. (2020). Inclusion of positive self-reporting by mothers of substance exposed neonates increases the predictability of NAS severity over toxicology alone. Maternal and Child Health Journal, 24(3), 340–350. https://doi.org/10.1007/s10995-019-02871-9
Roussotte, F. F., Bramen, J. E., Nunez, S. C., Quandt, L. C., Smith, L., O’Connor, M. J., Bookheimer, S. Y., & Sowell, E. R. (2011). Abnormal brain activation during working memory in children with prenatal exposure to drugs of abuse: The effects of methamphetamine, alcohol, and polydrug exposure. NeuroImage, 54(4), 3067–3075. https://doi.org/10.1016/j.neuroimage.2010.10.072
Salas-Wright, C. P., Vaughn, M. G., & Ugalde, J. (2016). A typology of substance use among pregnant teens in the United States. Maternal and Child Health Journal, 20(3), 646–654. https://doi.org/10.1007/s10995-015-1864-1
Salzwedel, A. P., Grewen, K. M., Vachet, C., Gerig, G., Lin, W., & Gao, W. (2015). Prenatal drug exposure affects neonatal brain functional connectivity. Journal of Neuroscience, 35(14), 5860–5869. https://doi.org/10.1523/JNEUROSCI.4333-14.2015
Sanlorenzo, L. A., Cooper, W. O., Dudley, J. A., Stratton, S., Maalouf, F. I., & Patrick, S. W. (2019). Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure. Hospital Pediatrics, 9(8), 569–575. https://doi.org/10.1542/hpeds.2018-0227
Schauberger, C. W., Newbury, E. J., Colburn, J. M., & Al-Hamadani, M. (2014). Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting. American Journal of Obstetrics and Gynecology, 211(3), 255251–255254. https://doi.org/10.1016/j.ajog.2014.03.023
Serino Ma, D., Peterson, B. S., & Rosen, T. S. (2018). Psychological functioning of women taking illicit drugs during pregnancy and the growth and development of their offspring in early childhood. Journal of Dual Diagnosis, 14(3), 158–170. https://doi.org/10.1080/15504263.2018.1468946
Shannon, L. M., Havens, J. R., & Hays, L. (2010). Examining differences in substance use among rural and urban pregnant women. The American Journal on Addictions, 19(6), 467–473. https://doi.org/10.1111/j.1521-0391.2010.00079.x
Shaw, M. R., Grant, T., Barbosa-Leiker, C., Fleming, S. E., Henley, S., & Graham, J. C. (2014). Intervention with substance-abusing mothers: Are there rural-urban differences? The American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.2014.12155.x
Shen, Y., Lo-Ciganic, W. H., Segal, R., & Goodin, A. J. (2020). Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009–2014. Journal of Psychosomatic Obstetrics & Gynecology. https://doi.org/10.1080/0167482X.2020.1727882
Shmulewitz, D., & Hasin, D. S. (2019). Risk factors for alcohol use among pregnant women, ages 15–44, in the United States, 2002 to 2017. Preventive Medicine, 124, 75–83. https://doi.org/10.1016/j.ypmed.2019.04.027
Shrestha, S., Jimenez, E., Garrison, L., Pribis, P., Raisch, D. W., Stephen, J. M., & Bakhireva, L. N. (2018). Dietary intake among opioid- and alcohol-using pregnant women. Substance Use and Misuse, 53(2), 260–269. https://doi.org/10.1080/10826084.2016.1265563
Smid, M. C., & Terplan, M. (2022). What obstetrician-gynecologists should know about substance use disorders in the perinatal period. Obstetrics and Gynecology, 139(2), 317–337. https://doi.org/10.1097/AOG.0000000000004657
Smith, M. V., Costello, D., & Yonkers, K. A. (2015). Clinical correlates of prescription opioid analgesic use in pregnancy. Maternal and Child Health Journal, 19(3), 548–556. https://doi.org/10.1007/s10995-014-1536-6
Stewart, R. D., Nelson, D. B., Adhikari, E. H., McIntire, D. D., Roberts, S. W., Dashe, J. S., & Sheffield, J. S. (2013). The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy. American Journal of Obstetrics and Gynecology, 209(3), 267 e261–265. https://doi.org/10.1016/j.ajog.2013.05.026
Stitely, M. L., Calhoun, B., Maxwell, S., Nerhood, R., & Chaffin, D. (2010). Prevalence of drug use in pregnant West Virginia patients. West Virginia Medical Journal, 106(4), 48–52.
Stroud, L. R., Papandonatos, G. D., Jao, N. C., Vergara-Lopez, C., Huestis, M. A., & Salisbury, A. L. (2020). Prenatal tobacco and marijuana co-use: Sex-specific influences on infant cortisol stress response. Neurotoxicology and Teratology, 79, 106882. https://doi.org/10.1016/j.ntt.2020.106882
Substance Abuse and Mental Health Services Administration. (2020a). 2020 NSDUH Detailed Tables: Table 6.20B—Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among Females Aged 15 to 44; by Pregnancy Status, Percentages, 2019 and 2020. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables
Substance Abuse and Mental Health Services Administration. (2020b). National Survey on Drug Use and Health (NSDUH). U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. https://www.datafiles.samhsa.gov/dataset/national-survey-drug-use-and-health-2020b-nsduh-2020b-ds0001
Tai, M., Piskorski, A., Kao, J. C., Hess, L. A., de la Monte, S. M., & Gundogan, F. (2017). Placental morphology in fetal alcohol spectrum disorders. Alcohol and Alcoholism, 52(2), 138–144. https://doi.org/10.1093/alcalc/agw088
Terplan, M., Smith, E. J., Kozloski, M. J., & Pollack, H. A. (2009). Methamphetamine use among pregnant women [Research Support, Non-US Gov’t]. Obstetrics & Gynecology, 113(6), 1285–1291. https://doi.org/10.1097/AOG.0b013e3181a5ec6f
The National Institute for Health Care Management (NIHCM) Foundation. (2022). Charting the Stimulant Overdose Crisis & the Influence of Fentanyl. The National Institute for Health Care Management (NIHCM) Foundation. Retrieved December 22, 2022 from https://nihcm.org/publications/stimulant-drug-overdose-deaths-2022-update
Tith, S., Bining, G., & Bollag, L. (2018). Management of eight labor and delivery patients dependent on buprenorphine (Subutex): A retrospective chart review. F1000Research, 7, 7. https://doi.org/10.12688/f1000research.13350.2
Towers, C. V., Hyatt, B. W., Visconti, K. C., Chernicky, L., Chattin, K., & Fortner, K. B. (2019). Neonatal head circumference in newborns with neonatal abstinence syndrome. Pediatrics. https://doi.org/10.1542/peds.2018-0541
Towers, C. V., Katz, E., Weitz, B., & Visconti, K. (2020). Use of naltrexone in treating opioid use disorder in pregnancy. American Journal of Obstetrics and Gynecology, 222(1), 83e81-83e88. https://doi.org/10.1016/j.ajog.2019.07.037
U.S. Census Bureau. (2021). Census Regions and Divisions in the United States. U.S. Department of Commerce, U.S. Census Bureau. https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf
U.S. Food and Drug Administration. (2017). FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks. U.S. Department of Health and Human Services, U.S. Food and Drug Administration. Retrieved October 6, 2021 from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-urges-caution-about-withholding-opioid-addiction-medications
van Gelder, M. M., Reefhuis, J., Caton, A. R., Werler, M. M., Druschel, C. M., Roeleveld, N., National Birth Defects Prevention Study. (2010). Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug and Alcohol Dependence, 109(1–3), 243–247. https://doi.org/10.1016/j.drugalcdep.2010.01.007
Wachman, E. M., Newby, P. K., Vreeland, J., Byun, J., Bonzagni, A., Bauchner, H., & Philipp, B. L. (2011). The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. Journal of Addiction Medicine, 5(4), 293–299. https://doi.org/10.1097/ADM.0b013e3182266a3a
Washio, Y., Mark, K., & Terplan, M. (2018). Characteristics of pregnant women reporting cannabis use disorder at substance use treatment entry. Journal of Addiction Medicine, 12(5), 395–400. https://doi.org/10.1097/ADM.0000000000000424
Washio, Y., Martin, C. E., Goldstein, N. D., & Terplan, M. (2017). Characteristics of pregnant women who reported alcohol use at admission to substance use treatment. Journal of Substance Abuse Treatment, 82, 82–86. https://doi.org/10.1016/j.jsat.2017.09.010
Winhusen, T., & Lewis, D. (2017). Cigarette smoking in pregnant substance users: Association with substance use and desire to quit. Journal of Addictive Diseases, 36(1), 88–91. https://doi.org/10.1080/10550887.2016.1254992
Witt, W. P., Mandell, K. C., Wisk, L. E., Cheng, E. R., Chatterjee, D., Wakeel, F., Park, H., & Zarak, D. (2015). Predictors of alcohol and tobacco use prior to and during pregnancy in the US: The role of maternal stressors. Archives of Women’s Mental Health, 18(3), 523–537. https://doi.org/10.1007/s00737-014-0477-9
Wood, K. E., Sinclair, L. L., Rysgaard, C. D., Strathmann, F. G., McMillin, G. A., & Krasowski, M. D. (2014). Retrospective analysis of the diagnostic yield of newborn drug testing. BMC Pregnancy and Childbirth, 14, 250. https://doi.org/10.1186/1471-2393-14-250
Wouldes, T. A., LaGasse, L. L., Derauf, C., Newman, E., Shah, R., Smith, L. M., Arria, A. M., Huestis, M. A., DellaGrotta, S., Wilcox, T., Neal, C. R., Jr., & Lester, B. M. (2013). Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug and Alcohol Dependence, 127(1–3), 101–107. https://doi.org/10.1016/j.drugalcdep.2012.06.016
Wright, T. E., Milam, K. A., Rougee, L., Tanaka, M. D., & Collier, A. C. (2011). Agreement of umbilical cord drug and cotinine levels with maternal self-report of drug use and smoking during pregnancy. Journal of Perinatology, 31(5), 324–329. https://doi.org/10.1038/jp.2010.132
Wright, T. E., Schuetter, R., Tellei, J., & Sauvage, L. (2015). Methamphetamines and pregnancy outcomes. Journal of Addiction Medicine, 9(2), 111–117. https://doi.org/10.1097/ADM.0000000000000101
Acknowledgements
The authors acknowledge Joanna Taliano from the Centers for Disease Control and Prevention (CDC) library for assistance with the systematic literature search, Gitangali B. Baroi from the CDC for assistance with the initial title and abstract screening phase of the review, and Lucas K. Gosdin from the CDC for assistance with the development of Fig. 2. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Funding
This project was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the Centers for Disease Control and Prevention.
Author information
Authors and Affiliations
Contributions
ELT, LJE, YP, and CHD led the evidence acquisition. ELT led the synthesis of evidence, data analysis, and writing of the manuscript. LJE, CHD, and SYK provided conceptualization oversight. LJE, YP, CHD, and SYK provided guidance, subject matter input, and manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
No conflicts of interest were reported by the authors of this paper.
Ethical Approval
Not applicable (the manuscript is not based upon clinical study or patient data).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Appendix
Appendix
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tran, E.L., England, L.J., Park, Y. et al. Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009–2020. Matern Child Health J 27, 426–458 (2023). https://doi.org/10.1007/s10995-023-03592-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-023-03592-w